Keyphrases
Glucagon-like
100%
Glucose-dependent Insulinotropic Polypeptide
67%
Glucagon
56%
Sandwich ELISA
40%
Glucagon Secretion
39%
L-cells
32%
Glucose Tolerance
29%
Peptide YY
29%
Type 2 Diabetes Mellitus (T2DM)
28%
Gut Hormones
28%
Glucose Metabolism
24%
Incretin Hormones
24%
Oral Glucose Tolerance Test
23%
Anesthesia
23%
Secretin
21%
Enteroendocrine Cells
21%
Bone Metabolism
21%
2-oleoylglycerol
21%
Insulin
21%
Glucagon-like peptide-1 (GLP-1)
20%
2-monoacylglycerol
20%
Physiological Role
18%
Hyperglucagonemia
18%
Novel Locus
18%
Glucagon Action
18%
Fatty Acids
18%
Fructose
18%
Overweight Subjects
18%
Gene-deficient Mice
18%
Energy Intake
18%
Osteoporosis Treatment
18%
Enhanced Green Fluorescent Protein (eGFP)
18%
Hormone Secretion
18%
K Cells
18%
Neurotensin
18%
Diabetic Mouse Model
18%
Hypermethylation
18%
Locus-specific
18%
Methylation Pattern
18%
Glucose-insulin System
18%
Insulin Secretion
18%
Potential Drugs
18%
Breast Cancer
18%
Methylation
18%
Drug Therapy
18%
G Protein-coupled Receptor 119
18%
Gastric Inhibitory Peptide
18%
Somatostatin
18%
Olive Oil
18%
Prodrug
18%
Medicine and Dentistry
Gastric Inhibitory Polypeptide
70%
Glucagon Like Peptide 1
57%
Peptide YY
37%
Secretion (Process)
24%
Receptor
24%
Gastrointestinal Hormone
24%
Insulin Release
23%
Glucagon Release
20%
Cholecystokinin
20%
Bone Remodeling
20%
Drug Therapy
18%
Fructose
18%
Secretin
18%
Somatostatin
18%
Osteoporosis
18%
ELISA Sandwich
18%
Neurotensin
18%
Enteroendocrine Cell
18%
Glucose Tolerance
18%